Uses of Bortesam 2 mg Injection
Multiple myeloma and Mantle cell lymphoma.
Medicinal Benefits
Bortesam 2 mg Injection 1's contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. Bortesam 2 mg Injection 1's is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It can be used alone or together with other medicines.
Directions for Use
Bortesam 2 mg Injection 1's will be administered by a qualified healthcare professional. Kindly do not self-administer.
Storage
Store in a cool and dry place away from sunlight
Side Effects of Bortesam 2 mg Injection
- Nausea
- Diarrhoea
- Thrombocytopenia (low blood platelet count)
- Neutropenia (too few neutrophils)
- Peripheral neuropathy (nerves malfunction)
- Fatigue (overtired)
- Neuralgia (pain in the head or face)
- Muscle pain, bone pain
- Anaemia (low red blood cell Count)
- Leukopenia (Low White Blood Cell Count)
- High blood pressure
- Constipation
- Dehydration
- Vomiting
- Loss of appetite
- Lymphopenia (Low lymphocytes Count)
- Rash
- Pyrexia (raised body temperature)
- Anorexia (lack or loss of appetite for food)
- Infections, including pneumonia, respiratory infections, bronchitis, fungal infections, coughing with phlegm, flu-like illness
In-Depth Precautions and Warning
Drug Warnings
To treat your condition effectually, continue taking Bortesam 2 mg Injection 1's for as long as your doctor has prescribed. Do not stop the Bortesam 2 mg Injection 1's midway. Talk to your doctor before taking Bortesam 2 mg Injection 1's if you have allergies or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. And also, inform your doctor if you have diabetes because this medicine can affect your blood glucose levels. Your doctor may require close monitoring of your blood glucose levels and change your diabetes medicine dose while being treated with Bortesam 2 mg Injection 1's. Avoid taking Bortesam 2 mg Injection 1's if you are pregnant because this Bortesam 2 mg Injection 1's can cause harmful effects on the unborn baby. Both women and men using this Bortesam 2 mg Injection 1's should use birth control to avoid pregnancy and for at least six months following treatment. Do not breastfeed during treatment with Bortesam 2 mg Injection 1's and four months after your final dose of Bortesam 2 mg Injection 1's.
Drug Interactions
Drug-Drug Interactions: Bortesam 2 mg Injection 1's interacts with antifungal medication (ketoconazole), HIV medication (ritonavir), antibiotic medication (rifampicin), epilepsy medications (carbamazepine, phenytoin or phenobarbital), depression medication (St. John’s Wort), and oral antidiabetics.
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking Bortesam 2 mg Injection 1's; it requires close monitoring if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), and hepatic disorders.